ChiCTR2100049349
Untitled Trial
Phase I clinical trial to evaluate the safety, tolerability and preliminary explored immunogenicity of the new coronavirus mRNA vaccine (LVRNA009) in Chinese people aged 18 years and over
Shulan (Hangzhou) Hospital·Phase 1·Chinese Clinical Trial RegistryNot yet recruiting
View on Chinese Clinical Trial Registry →Study focus
- Disease/Condition
- Novel Coronavirus Pneumonia (COVID 19)
Sponsor & location
- Primary sponsor
- Shulan (Hangzhou) Hospital
- Funder
- Self financed
- Location
- China
Timeline & enrollment
- Phase
- Phase 1
- Start date
- N/A
- End date
- Dec 31, 2022
ICD-10 classifications
COVID-19, virus identifiedViral pneumonia, unspecifiedOther viral pneumoniaCOVID-19, virus not identifiedPneumonia in viral diseases classified elsewhere
Data source
- Registry
- Chinese Clinical Trial Registry
- Trial ID
- ChiCTR2100049349
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for ChiCTR2100049349 through Pure Global AI's free database. This Phase 1 trial is sponsored by Shulan (Hangzhou) Hospital and is currently Not yet recruiting. The study focuses on Novel Coronavirus Pneumonia (COVID 19).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.